Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
30.04.AstraZeneca unfolds first DTC TV ad for breast cancer med Truqap
30.04.Sanofi nets €10B from Opella sale, eyes more 'bolt-on' deals
30.04.As vaccine sales slip, GSK touts 'mitigation options' for potential drug tariffs
30.04.J&J joins Argenx, UCB in the myasthenia gravis arena with FDA approval for FcRn blocker Imaavy
30.04.Charles Barkley boards Ro's GLP-1 ad push, signing up to take a 2nd shot at weight loss
29.04.Gilead enters $202M settlement to resolve US government's long-running HIV kickbacks probe
29.04.AstraZeneca's highly touted Truqap flunks another phase 3 trial
29.04.Bipartisan House lawmakers try again to cut tax breaks for DTC drug ads
29.04.Regeneron's Eylea franchise suffers double whammy with sales decline and surprise FDA rejection
29.04.Pfizer, in sweeping cost cutting push, lifts overall savings target to $7.7B
29.04.Novo moves past GLP-1 spat with Hims & Hers, tapping telehealth company to offer discounted Wegovy
29.04.As Novartis builds momentum with new drug launches, CEO says he's 'comfortable' navigating US tariffs
29.04.Merck begins construction on $1B Keytruda manufacturing facility in Delaware
29.04.Abeona enters commercial gene therapy arena with FDA nod for Zevaskyn to treat rare genetic skin disease
29.04.Bayer gets industry discredit ruling overturned after accusation of 'warming the market' for Eylea launch
28.04.Daiichi Sankyo, AstraZeneca's highly touted ADC Datroway off to 'smooth market launch'
28.04.PCI's expansion tear rolls on with acquisition of fill-finish CDMO Ajinomoto Althea
28.04.Delivering Hope: Building a Network to Deliver Radioligand Therapies
28.04.AACR: Merck's Keytruda prevents head and neck cancer from returning in industry-first win
28.04.Merck KGaA springs back into M&A game with $3.9B buyout of Pfizer spinout SpringWorks
28.04.French health authorities suspend use of Valneva's chikungunya vaccine in older adults to probe 3 hospitalizations, one death
28.04.Regeneron scores EU nod for bispecific antibody Lynozyfic, setting up clash with J&J and Pfizer
28.04.'Deviated from core': Akeso CEO tries to reset expectations of bispecific's survival readout amid market tumult
27.04.As J&J aims to 'fundamentally change' how bladder cancer type is treated, ImmunityBio plays defense
25.04.Summit stock crashes as Akeso shares bispecific's first overall survival data in Keytruda head-to-head trial